BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15233659)

  • 1. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage?
    Guda NM; Noonan M; Kreiner MJ; Partington S; Vakil N
    Am J Gastroenterol; 2004 Jul; 99(7):1233-7. PubMed ID: 15233659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences.
    Schneeweiss S; Maclure M; Dormuth CR; Glynn RJ; Canning C; Avorn J
    Clin Pharmacol Ther; 2006 Apr; 79(4):379-88. PubMed ID: 16580906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous proton pump inhibitor therapy: a rationale for use.
    Armstrong D
    Rev Gastroenterol Disord; 2005; 5 Suppl 2():S18-30. PubMed ID: 16369224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors: a survey of prescribing in an Irish general hospital.
    Mat Saad AZ; Collins N; Lobo MM; O'Connor HJ
    Int J Clin Pract; 2005 Jan; 59(1):31-4. PubMed ID: 15707461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous proton pump inhibitors.
    Baker DE
    Rev Gastroenterol Disord; 2006; 6(1):22-34. PubMed ID: 16520709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.
    Kaplan GG; Bates D; McDonald D; Panaccione R; Romagnuolo J
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1207-14. PubMed ID: 16361046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
    Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
    Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonix. First i.v. proton pump inhibitor approved.
    Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less acid + less bleeding = better outcomes and more money!
    Enns R
    Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug interactions. Proton pump inhibitors II].
    Zaigler M
    Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
    [No Abstract]   [Full Text] [Related]  

  • 19. [Choice of proton pump inhibitors--does it play any role?].
    Hellström PM
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2620-1. PubMed ID: 15534636
    [No Abstract]   [Full Text] [Related]  

  • 20. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
    Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
    Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.